NP / PA
Tobitt, Timothy
Tobitt, Timothy was paid $252K by Medicaid between Jan 2018 and Nov 2024, across 15 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 70% of everything it billed.
33Billing provider infoTOBITT, TIMOTHY
SMITHVILLE, TN 37166
SMITHVILLE, TN 37166
33aNPI1396923199assigned 02/04/2008
33bProvider typeFamily Nurse Practitioner
28Total paid$252K
24GClaims13,873
24DCodes billed15
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Tennessee
Rank by total paid#72 of 687
Median peer was paid$15K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,398 | $48K | |
| 2019 | 2,556 | $45K | |
| 2020 | 1,712 | $32K | |
| 2021 | 2,239 | $41K | |
| 2022 | 1,834 | $32K | |
| 2023 | 1,920 | $30K | |
| 2024incomplete | 1,214 | $24K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 70% | 5,614 | 4,372 | $177K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 14% | 3,032 | 2,003 | $35K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.7% | 414 | 381 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.9% | 240 | 202 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.6% | 813 | 363 | $9K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 96 | 79 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 840 | 707 | $1K |
| G0008 | Administration of influenza virus vaccine | <1% | 139 | 127 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 160 | 150 | $968.17 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 23 | 23 | $748.74 |
| Q2037 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | <1% | 71 | 69 | $729.92 |
| 36415 | Collection of venous blood by venipuncture | <1% | 620 | 551 | $527.29 |
3 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.